Pacira BioSciences maintained at Buy by Truist Securities
Truist Securities maintained a Buy rating on Pacira BioSciences, according to ratings actions reported by Benzinga.
Story updates
05:13:44 PM UTC
SquawkNews
Pacira BioSciences Is Maintained at Buy by Truist Securities